tDCS-Augmented Exposure Therapy for Pathological Fear

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

September 6, 2018

Study Completion Date

September 6, 2018

Conditions
Specific Phobias
Interventions
DEVICE

Transcranial Direct Current Stimulation (tDCS)

Participants will receive 20 minutes of either active or sham tDCS prior to in vivo exposure to feared targets.

BEHAVIORAL

In vivo exposure therapy

Participants will receive 30 minutes of in vivo exposure to feared targets following either active or sham tDCS

Trial Locations (1)

78712

Laboratory for the Study of Anxiety Disorders, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER

NCT03095482 - tDCS-Augmented Exposure Therapy for Pathological Fear | Biotech Hunter | Biotech Hunter